Font Size:
a
A
A
Keyword [HER2]
Result: 1 - 20 | Page: 1 of 2
1.
Carry Oxaliplatin, Herceptin Composite Metal Nanoparticles On Molecular Targeting HER2-positive Of Gastric
2.
Separation Of Anti-HER2 And Anti-IL-12/23 Monoclonal Antibodies By Hydrophobic Charge-induction Chromatography
3.
Production Of Recombinant Extracellular Domain Of Human HER2and Screening Of Specific VHH Nanobodies
4.
Preparation, Activity In Vitro, Linker Based Optimization Of Recombinant Immunotoxin Gigantoxin-4-4D5 ScFv
5.
Construction Of HER2-targeted DNA Nanocarriers Incorporating Polymeric 5-fluorodeoxyuridine And Their Antitumor Applications
6.
Application Of Hydrophilic Modified Affinity Molecule Probe In HER2 Over Expression Breast Cancer
7.
The HER2-Targeted Chemo-photothermal Combined Studies Of Aptamer-conjugated Mesoporous Silica-carbon Nanoparticles
8.
Preparation And Imaging Investigation Of Dual-Targeted Poly(Lactic-Co-Glycolic Acid)Ultrasound Contrast Agent Carrying Anti-HER2 And VEGFR2 Antibodies
9.
Nanostructure Surface Plasma Resonance Enhanced Fluorescence And Cellular Membrane HER2 Receptor Dimerization Inhibition Analysis
10.
Investigations Of Molecular Imaging Probes From Radionuclide-and Fluorescent-labeled HER2 Nanobodies
11.
Targeting MOFs Loaded With Fluorouracil Deoxynucleoside For Breast Cancer Treatment
12.
Radioiodinated Small-Molecule Tyrosine Kinase Inhibitors For HER2-Selective SPECT Imaging Of Breast Cancer
13.
Trastuzumab-decorated Multifunctional Polymersomes For Targeted Ovarian Cancer Chemotherapy
14.
Studies On Preparation And Critical Factors Of Recombinant Anti-HER2 Antibody-Drug Conjugate
15.
Radionuclide
68
Ga And Fluorescence Labeled HER2 Nanobody Probes For The PET/NIRF Optical Imaging Of Cancer
16.
Biochemical Characterization Of The Engineered Penetrative Nanobody Targeting Her2 Positive Breast Cancer Cells
17.
The Development Of Conjugation Process For Anti-Her2 Antibody Drug Conjugate
18.
Biodegradable Anti-HER2 Monoclonal Antibody/PCL-PEG/Paclitaxel Worm-like Nanocrystal Micelles For Treatment Of HER2-positive Breast Cancer
19.
Study On Molecularly Imprinted Nanoparticles-based Cancer Targeted Therapy
20.
Screening And Preliminary Evaluation Of Antibody-drug Conjugate (ADC) Targeting HER2+
<<First
<Prev
Next>
Last>>
Jump to